Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment (2018)

First Author: Sliz E
Attributed to:  Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/278861

Publication URI: http://dx.doi.org/10.1101/278861

Type: Preprint